BetterLife Pharma Files Routine 6-K Report

Ticker: BETRF · Form: 6-K · Filed: May 7, 2025 · CIK: 1464165

Sentiment: neutral

Topics: reporting, foreign-private-issuer, routine-filing

Related Tickers: BETRF

TL;DR

BetterLife Pharma (BETRF) filed a standard 6-K, nothing major to see here.

AI Summary

BetterLife Pharma Inc. filed a Form 6-K on May 7, 2025, reporting for the month of May 2025. The company, formerly known as Pivot Pharmaceuticals Inc. and Neurokine Pharmaceuticals Inc., is incorporated in A1 and has its principal executive offices in Vancouver, BC. This filing is a routine report for foreign private issuers.

Why It Matters

This filing indicates BetterLife Pharma Inc. is fulfilling its reporting obligations as a foreign private issuer, which is standard practice for companies listed on US exchanges but incorporated elsewhere.

Risk Assessment

Risk Level: low — This is a routine filing by a foreign private issuer and does not contain new material financial information or strategic changes.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, used to provide information that the issuer would be required to disclose to its home country security holders.

When was BetterLife Pharma Inc. previously known by other names?

BetterLife Pharma Inc. was formerly known as Pivot Pharmaceuticals Inc. (name change date: 20150417) and Neurokine Pharmaceuticals Inc. (name change date: 20090514).

Where are BetterLife Pharma Inc.'s principal executive offices located?

The principal executive offices of BetterLife Pharma Inc. are located at 1275 WEST 6TH AVENUE, #300 VANCOUVER, BC V6H 1A6.

What is the SIC code for BetterLife Pharma Inc.?

The Standard Industrial Classification (SIC) code for BetterLife Pharma Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Does BetterLife Pharma Inc. file annual reports under Form 20-F or Form 40-F?

BetterLife Pharma Inc. indicates it files annual reports under cover of Form 20-F.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on May 7, 2025 regarding BetterLife Pharma Inc. (BETRF).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing